CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy. Soares F, Chen B, Lee JB, Ahmed M, et al. Blood 2021;137:2171-2181.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Soares F, Chen B, Lee JB, Ahmed M, et al. CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy. Blood 2021;137:2171-2181.
PMID: 33270841